Vir Biotechnology Inc (VIR)
Current ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 1,042,460 | 1,588,230 | 2,519,080 | 1,562,820 | 772,365 |
| Total current liabilities | US$ in thousands | 119,662 | 175,407 | 511,029 | 341,242 | 99,064 |
| Current ratio | 8.71 | 9.05 | 4.93 | 4.58 | 7.80 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $1,042,460K ÷ $119,662K
= 8.71
The current ratio of Vir Biotechnology Inc has exhibited fluctuating trends over the past five years. As of December 31, 2020, the current ratio stood at a strong level of 7.80, indicating a comfortable ability to meet short-term obligations with current assets. However, this ratio decreased to 4.58 by December 31, 2021, suggesting a potential liquidity strain compared to the previous year.
In the subsequent years, the current ratio showed improvements, reaching 4.93 by December 31, 2022, and further increasing to 9.05 by December 31, 2023, signifying a significant enhancement in the company's liquidity position. By December 31, 2024, the current ratio slightly decreased to 8.71, but still remained at a robust level.
Overall, the current ratio of Vir Biotechnology Inc has demonstrated volatility, with some years showing strong liquidity positions while others indicating potential challenges in meeting short-term obligations. Investors and stakeholders may want to monitor this ratio closely to assess the company's ability to manage its current liabilities effectively in the future.
Peer comparison
Dec 31, 2024